smarteeva’s Post

𝐕𝐢𝐫𝐭𝐮𝐚𝐥 𝐂𝐨𝐥𝐨𝐧𝐨𝐬𝐜𝐨𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 The virtual colonoscopy market is witnessing significant growth due to rising demand for minimally invasive diagnostic techniques, technological advancements in imaging, and increasing awareness of colorectal cancer screening. Supportive government initiatives and expanding healthcare infrastructure further boost market prospects. 𝐆𝐞𝐭 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨 @ Visti Us- https://lnkd.in/ddsjcxTa 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 GE HealthCare, Philips FUJIFILM Diosynth Biotechnologies Boston Scientific Medtronic, KARL STORZ Cook Medical Hologic, Inc., Bracco Medical Technologies SHIMADZU CORPORATION Carestream ViewRay, Inc., INFINITT Healthcare Novarad, Accuray, Varian Analogic 3DISC Esaote, Planmed , ContextVision AB, Infraredx, a Nipro Company Delphinus Medical Technologies, Inc. Volpara Health Ziosoft, Radiological Society of North America (RSNA) Cephasonics Ultrasound, Quantib, MedisMed Riverain Technologies Imalogix Aidence #HealthcareInnovation #MedicalTechnology #VirtualColonoscopy #MarketGrowth

The #ablationdevices market is seeing growth due to advancements in minimally invasive techniques and precision technology. New methods, like radiofrequency and cryoablation, are offering targeted treatments with reduced recovery times. Robotic-assisted ablation devices and integration with imaging technologies enhance accuracy, improving outcomes. These innovations are driving adoption in cancer treatments, #cardiovascular procedures, and pain management, contributing to the market's expansion and demand for effective, efficient solutions. To know more, visit https://lnkd.in/gibcTtm7 #AblationDevices #MedicalAblation #CardiacAblation #AblationTherapy #InterventionalCardiology #RadiofrequencyAblation #MinimallyInvasive #AblationTechnology #CancerAblation #Electrophysiology

🚀 Great insights shared by Benjamin Davies at ISCOS Antwerp! Professor Armin Curt’s keynote highlighted the ongoing challenge of running clinical trials in spinal cord injury (SCI), where traditional biomarkers and large sample sizes often struggle to capture meaningful changes. 🔍 This is where MoveMed can make a difference. By combining sensitive neuromuscular monitoring with patient-reported outcomes, we can help detect subtle improvements and offer insights with fewer participants—reducing the scale, cost, and complexity of trials. 💡 We’re excited to see how MoveMed could support researchers in overcoming these barriers and advancing SCI treatment for better patient outcomes! 💪 If you're working on translating therapies in SCI, we’d love to connect. Get in touch to explore how MoveMed can help accelerate your clinical research! #ClinicalTrials #SCI #Innovation #MoveMed #PatientPerspective #ISCOS2024

A Complete Guide On #Molecular_Imaging Molecular imaging is a technique used to visualize, characterize, and quantify biological processes at the molecular and cellular levels within living organisms. It involves the use of imaging technologies such as PET, MRI, or CT scans, often combined with targeted probes or biomarkers, to detect specific molecular changes associated with diseases like cancer, cardiovascular disorders, or neurological conditions. This non-invasive approach allows for early diagnosis, monitoring of treatment efficacy, and personalized medicine by providing detailed insights into biological functions and disease mechanisms at the molecular scale. 📚 For More Information☛ https://lnkd.in/d-RdUMdm KeyPlayers - Hermes Medical Solutions, Bruker, Gecompany Sac, FUJIFILM Holdings Corporation, Koninklijke Kentalis, Siemens, Toshiba America Medical Systems, MIRADA MEDICAL LIMITED #molecularimaging #medicalimaging #diagnosticimaging #nuclearmedicine #radiology #petscan #mri #ctscan #fluorescenceimaging #biomarkers #imagingresearch #cancerimaging #personalizedmedicine #clinicaltrials #healthtech #medicalinnovation #invivoimaging #preclinicalimaging #theranostics

New Insights Into Imaging article on #liver imaging! 🎯 This fully automated convolutional neural network (CNN) model, using pre-contrast MRI, age, and serum biomarkers, diagnosed cirrhosis with an AUC of 0.86 in the external testing set. #RobertosPick European Society of Radiology European School of Radiology (ESOR) European Radiology Gennaro D'Anna Sonja Jankovic Brendan Kelly European Society of Gastrointestinal and Abdominal Radiology - ESGAR

Tianying Zheng et al. developed and validated a fully automated CNN model for diagnosing cirrhosis based on liver MRI and serum biomarkers. The combined model outperformed APRI, FIB-4, and two radiologists, achieving an AUC of 0.86 and showed moderate accuracy, independent of focal liver lesion size. #InsightsIntoImaging 🔗 https://buff.ly/4h9xwio

Protective Effects of Intratympanic Dexamethasone on Radiation-Induced Middle Ear Mucosal Damage : The study investigated the effects of dexamethasone (DEX) administration prior to radiotherapy in rats, specifically examining its impact on the middle ear and Eustachian tube. The researchers found that DEX pretreatment significantly reduced radiation-induced damage to the middle ear cavity and Eustachian tube thickness at both 1 and 4 months post-radiation. The research included both in vivo and in vitro experiments, with cell studies showing DEX helped reduce radiation-induced cell death and mitochondrial stress in human middle ear epithelial cells. Read more: https://lnkd.in/djcd5QPA #dexamethasone #ent #medicalresearch #clinicalresearch #medicalupdate #medicalupdates #medicalnews #pharmaupdate #pharmaupdates #pharmanews #healthcareupdate #healthcareupdates #healthcarenews #hcp #scientificupdate #clinicalguideline #clinicalguidelines #medicalguideline #medicalguidelines #carbonbrandsolutions

Minute in Medtech: A perspective from an aspiring biomedical engineer, competitive cyclist, CHD Warrior, and typical(?) Teen… "Minimally invasive isn’t minimal enough” This quote is part of the landing page for the company HistoSonics, Inc. If you scroll a little further, you can understand the reasoning behind the suffix “sonics”. Histosonics creates a device called the Edison Histotripsy System, which uses histotripsy to treat liver tumors from outside the body. Histotripsy is a high-amplitude ultrasound in short pulses that generates a “bubble cloud” meant to physically destroy the liver tumor. The device mounts directly over the body, allowing the clinician to see internally and then begin treatment. We currently have external radiation therapy, which can be used similarly to treat tumors all over the body. The issue with radiation is its general beam which can often harm healthy cells. Histotripsy treatment is a safer alternative, as it only breaks down defective cells into smaller pieces for the body to naturally eradicate. This approach is very modern. It’s hard to say how easily the Edison Histotripsy System can be employed in hospitals, as it can only treat liver cancer, and the machine itself takes up a large floor space. However, I can see how the added safety benefits and new technology could be appealing. Thanks for reading! If you are interested in more of what Histosonics is doing, check them out using this link: https://histosonics.com/ Follow me at #MinuteInMedtech for more innovative and interesting medical devices. This is my opinion, and I am not being compensated for this post. #healthcare #medicine #medicaldevices #digitalhealth #medtech #medicaldevice #medtechinnovation #medtechinnovator #healthcareinnovation #biomedical #cancer #tumor #liver #sound #ultrasound #histotripsy

🔍 Market Intelligence Alert: Breast Lesion Localization Market Set for Robust Growth 📥 Download the PDF: https://lnkd.in/dUAXtamz The global breast lesion localization market is poised for significant expansion, projected to reach $0.4 billion by 2028 from $0.3 billion in 2023, achieving a steady CAGR of 6.9%. Key Market Segments: • Technology: Wire, Radioisotope (ROLL, RSL), Magnetic, and Electromagnetic Localization • Applications: Breast Biopsy and Lumpectomy procedures • End Users: Hospitals, Diagnostic Imaging Centers, and Ambulatory Surgical Centers What's Driving Growth? 📈 - Rising breast cancer awareness and screening programs - Technological advancements in localization techniques - Growing preference for minimally invasive procedures - Expanding healthcare infrastructure worldwide #HealthcareTechnology #MedicalDevices #BreastCancer #MarketAnalysis #HealthcareInnovation #MedTech

🌐 RADIOTHERAPY NEWS 🌐 This article reviews global collaborative research on proton radiotherapy Current research trends focused around research on technology development, dose calculation and relative biological effectiveness 👇 https://lnkd.in/ep7uGceE National Library of Medicine (NLM) #cancercare #CancerCare4All #CatchUpWithCancer #CloseTheCareGap